(Total Views: 630)
Posted On: 03/10/2022 1:14:44 PM
Post# of 72445
$200 million in total from Barda for this company.
They are doing mild to moderate....activ 2 trial.
https://www.sabbiotherapeutics.com/2021/09/24...-covid-19/
https://www.sabbiotherapeutics.com/2021/09/22...-covid-19/
Why in he** can we not get at least $10-20 million from Barda for an activ2 trial of hospitalized mild to moderate and non-hospitalized mild to moderate.
The results at GMU should have warranted something....
We should have done mild to moderate to BEGIN WITH....reduce risk...
Anyone know the best way to contact our CEO.
They are doing mild to moderate....activ 2 trial.
https://www.sabbiotherapeutics.com/2021/09/24...-covid-19/
https://www.sabbiotherapeutics.com/2021/09/22...-covid-19/
Why in he** can we not get at least $10-20 million from Barda for an activ2 trial of hospitalized mild to moderate and non-hospitalized mild to moderate.
The results at GMU should have warranted something....
We should have done mild to moderate to BEGIN WITH....reduce risk...
Anyone know the best way to contact our CEO.
(2)
(0)
